Hormone Pellet Therapy: A Clinical Overview for Providers

Written by Empire Medical Training Editorial Team

Medically reviewed by Betsy Greenleaf, DO Board-Certified OB/GYN & Urogynecologist; Empire Director of Anti-Aging

Updated June 2026 ·12 min read

Hormone pellet therapy is one of several delivery methods within bioidentical hormone replacement therapy (BHRT), and for many patients it is the one that finally makes treatment feel effortless. Instead of a daily cream or a twice-weekly injection, a small bioidentical pellet is placed under the skin and releases hormone on its own for months. For providers, the appeal is real, but so is the responsibility: a pellet, once in, cannot be dialed back, which makes patient selection, hormone stabilization, and monitoring more consequential than with any other route.

This guide is written for clinicians who want an accurate, practical overview of pellet therapy. It draws on the teaching of Dr. Betsy Greenleaf, DO — board-certified in OB/GYN and urogynecology and Empire's Director of Anti-Aging. It is clinical education, not medical advice, and deliberately omits patient-specific dosing, which belongs to current standards of care and individualized clinical judgment rather than a general resource page.

What is hormone pellet therapy?

Pellets are small, tablet-like compounds placed under the skin for the slow release of hormones. The hormones used are bioidentical — estradiol and testosterone that are molecularly identical to the hormones the human body already produces, rather than the synthetic or animal-derived estrogens used in older hormone products. That distinction matters clinically: as Dr. Greenleaf emphasizes, synthetic hormones have a higher binding affinity at the receptor, are often metabolized down less favorable pathways, and carry the clotting and cancer signals many patients associate with "hormones," whereas bioidentical molecules behave in the body the way native hormones do.

Because the implant sits in subcutaneous tissue and feeds hormone directly into the bloodstream, pellet therapy bypasses two problems that limit other routes. It avoids first-pass liver metabolism, so there is no strain on the liver of the kind seen with oral testosterone, and it is not subject to the gut-absorption variability that affects oral preparations. The result is high bioavailability and a delivery curve that is fundamentally different from creams, gels, or injections.

How pellets work: steady-state delivery

The defining feature of pellet therapy is steady-state release. Creams and injections produce a curve of ups and downs — a transdermal dose that rises and fades over a day, or an injection that peaks soon after administration and drifts down before the next one is due. A pellet, by contrast, dissolves gradually and delivers a relatively continuous hormone level for months. For patients who feel the swings of other methods, that steadiness is often the single biggest improvement.

An underappreciated detail is that pellet release is partly cardiac-output driven: dissolution and absorption increase with blood flow, so a more active patient can mobilize hormone from the pellet faster than a sedentary one. This is part of why absorption is not perfectly predictable from person to person, and why two patients with identical pellets can report different durations of effect.

Steady state is also where the clinical thinking gets interesting. The body tends to tune out hormone levels that never vary — it is the natural fluctuation that keeps receptors sensitive. Women have a monthly cycle; in men, testosterone peaks in the morning and runs higher in late summer and early fall. Because a pellet holds hormone at a constant level, a patient may report that the pellet "worked for a while and then stopped working," which is frequently receptor desensitization rather than a failing implant. Dr. Greenleaf's practical countermeasure is to space placement out — rather than re-dosing the moment a three-month pellet fades, extend the interval — and to consider bridging with a daily transdermal preparation to reintroduce some variability. This desensitization is seen most with testosterone, precisely because testosterone produces a noticeable sense of wellness and energy.

Composition and sourcing

Hormone pellets are compounded, typically as fused crystalline implants of a single bioidentical hormone — estradiol or testosterone — pressed into a solid form that dissolves predictably under the skin. Because they are compounded rather than mass-manufactured, the source pharmacy matters. Pellets are made under 503A (patient-specific compounding) or 503B (outsourcing-facility) frameworks, and providers should understand which they are using and hold their compounder to consistent quality.

That sourcing reality has a direct clinical consequence Dr. Greenleaf is explicit about: absorption of pellets can be inconsistent from person to person, from pharmacy to pharmacy, and from batch to batch. Bioidentical hormones are generally not patentable, which means there is little commercial incentive to fund large standardization studies, so the field lacks the tidy, fixed dosing tables that branded drugs offer. The discipline this demands — vet your pharmacy, expect batch variability, and confirm response with labs and symptoms rather than assuming the pellet "is" a given dose — is a core part of practicing pellet therapy well.

The insertion procedure

Pellet placement is a minor in-office surgical procedure. After local anesthesia, the pellet is introduced into the subcutaneous fat — commonly in the upper outer hip or buttock — through a trocar, a narrow tube-and-stylet instrument designed to deposit the implant beneath the skin through a small incision that is then closed without sutures. Because it is a surgical procedure, it carries real, if usually minor, risk, and it should be performed only by clinicians trained in sterile technique and correct placement.

This page intentionally omits the specifics — the dosing, the depth, the step-by-step trocar mechanics — because those are best learned hands-on under instruction rather than from a web page. For a fuller walkthrough of the technique itself, see our companion guide on the hormone pellet insertion procedure, and for the supervised, hands-on version, Empire's hormone pellet therapy training.

Benefits of pellet therapy

The advantages Dr. Greenleaf highlights are consistent and patient-centered:

• Steady hormone levels. Unlike methods that cause ups and downs, pellets hold a continuous level, which many patients experience as more even mood, energy, and symptom control.
• Convenience. Placement every three to six months removes the daily-cream or twice-weekly-injection burden, which is one of the strongest drivers of long-term adherence.
• High bioavailability. Subcutaneous delivery avoids first-pass liver metabolism and gut-absorption variability, so the hormone that is placed is the hormone that is delivered.
• Customizable dosing. Because pellets are compounded, the dose can be tailored to the individual rather than constrained to fixed manufactured strengths.
• Strong patient satisfaction. For ease of use relative to clinical response, patient satisfaction with pellets is consistently good.

Who is and isn't a candidate

The ideal candidates Dr. Greenleaf describes are menopausal women and andropausal men with symptoms, along with patients who have osteoporosis or medical conditions that cause hormonal imbalance — hypogonadism, premature menopause — and transgender individuals undergoing hormone therapy. Perimenopausal women can improve on pellets, but their care comes with a caveat: ovulation and pregnancy risk are still present, so contraception must be addressed before committing to a method that cannot be quickly withdrawn.

Just as important is the patient who is not ready, even when they want pellets. A recurring scenario in the course is the patient who arrives saying "my friend got pellets and feels great, so that's what I want." Dr. Greenleaf's discipline is to stabilize first: if a patient's hormones, inflammation, and stress are deranged — an estrogen-dominant, progesterone-deficient picture, an untreated thyroid problem, a stress-driven cortisol pattern stealing hormone production — placing a pellet too early can throw levels off further. The right move is often to hold pellets, correct the underlying imbalance, and return to the pellet conversation once labs and symptoms have settled. Patients respect that judgment, and it protects them from a decision that is hard to reverse. This is also where deeper hormone diagnostics matter; Empire's broader anti-aging and functional medicine training covers that workup in depth.

Safety, risks, and complications

Pellet therapy carries two categories of risk: procedural and hormonal. On the procedural side, because insertion is a minor surgery, the recognized local complications include extrusion (the pellet working its way back out through the incision), infection at the site, and bruising. Sterile technique and correct placement minimize these, which is precisely why hands-on training matters.

On the hormonal side, the defining caveat of pellets is the one that follows directly from steady-state delivery: there is a higher risk of overcorrection. Once a pellet is placed, it cannot be removed easily and the dose cannot be adjusted — you wait it out. If a patient is over-dosed, the body is held at that level for months. This is why Dr. Greenleaf's governing principle is start low and go slow, especially in a pellet-naive patient, and to follow symptoms and labs as the pellet does its work.

The hormone-specific contraindications apply with full force here because the exposure is sustained. Pellets are contraindicated in hormone-sensitive cancers (such as breast, uterine, or prostate cancer), a history of blood clots, stroke, or heart disease, liver disease, pregnancy or breastfeeding, unexplained vaginal bleeding, and allergy to the pellet or its components. Testosterone carries additional cautions including fluid retention, worsening sleep apnea, and elevated red blood cell count; estrogen carries thrombotic and other risks. A critical, easily missed safeguard Dr. Greenleaf stresses is uterine protection: because hormones interconvert, women with a uterus need progesterone protection even when the pellet is testosterone or DHEA, not estrogen alone.

Monitoring and follow-up

Pellet therapy is managed by following the patient, not a fixed number. There is no single hormone level at which everyone feels well; each patient has their own range, so treatment is guided by comparing symptoms and presentation against labs used as supportive factors. Baseline labs establish the starting picture, and follow-up labs confirm that a placed pellet is delivering the intended effect — remembering that batch and absorption variability mean the measured response, not the nominal dose, is what counts.

Dr. Greenleaf is candid that this is an iterative process. Stabilizing a patient's regimen can take time — occasionally up to a year in a complex case — and external events such as illness, major stress, or infection can disrupt a previously stable patient and require reassessment. Re-insertion timing is set by symptoms and labs rather than the calendar, and when receptor desensitization appears, the response is to lengthen the interval or bridge with a daily preparation rather than simply re-dosing. For the patient, the honest framing is that pellet therapy is a managed, evolving treatment, not a one-time fix.

Training for pellet therapy

Because insertion is a surgical procedure and because the steady-state pharmacology is unforgiving of dosing errors, pellet therapy is a competence to be learned hands-on, not improvised. The clinical reasoning on this page — bioidentical vs. synthetic hormones, steady-state delivery and receptor desensitization, candidacy and the discipline to stabilize first, contraindications, uterine protection, and start-low-go-slow monitoring — is the foundation. The procedural skill of safe, sterile trocar insertion and the protocol judgment for dosing and re-insertion are built in a supervised setting.

Empire Medical Training's hormone pellet therapy course, taught by Dr. Greenleaf, is designed for physicians and qualified clinicians who want to add pellets to a BHRT or anti-aging practice responsibly. It connects this pellet-specific skill set to the broader BHRT picture, including testosterone replacement therapy and BHRT for women.